Business
PURE Bioscience to Present at the 2016 Marcum MicroCap Conference on June 2nd
PURE Bioscience to Present at the 2016 Marcum MicroCap Conference on June 2nd.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented silver dihydrogen citrate (SDC) \n antimicrobial, announced today the Company will present at the 2016 \n Marcum MicroCap Conference at 11:30am EDT on Thursday, June 2, 2016 in \n New York City at the Grand Hyatt Hotel.\n \n \n Hank \n R. Lambert, CEO, will review progress of the commercialization of \n SDC as a food safety solution. For more information or to register and \n sign up for a one on one meeting with management, please visit the \n conference website at http://www.marcumllp.com/microcap.\n \n \n The presentation will be webcast live with slides (and available for \n replay) and can be accessed on the Company's website, http://www.purebio.com/investors/events-presentations/.\n \n \n About Marcum LLP\n \n \n Marcum LLP is one of the largest independent public accounting and \n advisory services firms in the nation, with offices in major business \n markets throughout the U.S., Grand Cayman and China. Headquartered in \n New York City, Marcum provides a full spectrum of traditional tax, \n accounting and assurance services; advisory, valuation and litigation \n support; and an extensive range of specialty and niche industry \n practices. The Firm serves both privately held and publicly traded \n companies, as well as high net worth individuals, private equity and \n hedge funds, with a focus on middle-market companies and closely held \n family businesses. In 2015, Marcum’s SEC Services Practice group led all \n non-“Big Four” accounting firms in the performance of audits in \n connection with Initial Public Offerings (\"IPOs\"). Marcum is a member of \n the Marcum Group, an organization providing a comprehensive array of \n professional services. For more information, visit www.marcumllp.com.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n form...